摘要
用国产尼莫地平注射液治疗急性缺血性脑血管病（ＡＩＣＶＤ）１０５例，疗效采用量表和５级标准分别评定。结果表明，尼莫地平组２周疗效显著优于对照组，３６ｈ内用药疗效显著优于３６ｈ后用药，尼莫地平有降压作用，此作用与剂量和滴速有关，无明显副作用。
The authors enrolled 105 patients with acute ischemic stroke in a clinical study of intravenous nimodipine. The therapeutic effects well evaluated with five-degree scale. During the two weeks treatment period, the results showed that intravenous nimodipine group has a significantly better neurologic outcome than control group. In intravenous nimodipine group, subgroup analysis showed those treated within 36 hours has statistically significantly better neurologic outcome than those without 36 hours. Blood pressure in the intravenous nimodipine treated patients decressed, and the effect on blood pressure may be related to concentration or dose. There was no major side effect except for two cases of fever and two cases of hiccup may have been related to treatment with nimodipine.
出处
《山东医科大学学报》
1995年第4期323-326,共4页
Acta Academiae Medicinae Shandong
